Update on NICE VTE Management Guidance and Safer Use of Anticoagulation in Primary Care

Sue Overton, MUS Team Administrator, Medicines Use and Safety (SPS)Event 14 October 2020Location Online

Pharmacy teams have a pivotal role in appropriate anticoagulation prescribing and monitoring

Date

14 October 2020

Location

Online

About the event

In this webinar, Frances and Alison outlined important issues from World Thrombosis week and key points from the NICE VTE guidelines (NG158, March 2020) and other recent outputs.

Why it’s important

Understanding the pathophysiology of thromboembolic disease helps you to advise on the most appropriate treatment for your patient.

What was covered

The following areas were discussed:

  • optimal diagnosis
  • duration of treatment
  • acute and long term DOAC dosing
  • DOACs in cancer
  • the MHRA safety alert for DOACS
  • the link between COVID-19 and thrombosis

Speakers

A range of speakers ran this event from SPS and other organisations

SPS speakers

Dr Barry Jubraj facilitated this event and you can read more about Barry by following the link.

Non-SPS speakers

Dr Frances Akor

Consultant Pharmacist
Imperial College Healthcare NHS Trust

Alison Warren

Consultant Pharmacist, Cardiology
Brighton and Hove CCG and Brighton and Sussex University Hospitals NHS Trust

Recording

Access the recording of the webinar

Presentation resources

Slides from the presentation are now available below

Contact us

Contact the Admin Team if you have any questions